Listed

Processa Pharmaceuticals, Inc.

PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Processa Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2013-08-0817:19 ET10-QQuarterly reportPeriod 2013-06-300001393905-13-000403
2013-07-1017:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-13-000342
2013-07-0913:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-13-000339
2013-06-2115:58 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001393905-13-000318
2013-05-2315:11 ETS-1/ARegistration statement, amended0001393905-13-000286
2013-05-1517:57 ETS-1/ARegistration statement, amended0001282869-13-000003
2013-04-1118:56 ETS-1/ARegistration statement, amended0001393905-13-000154
2013-03-1416:11 ETS-1/ARegistration statement, amended0001533743-13-000002
2013-01-1116:39 ETS-1/ARegistration statement, amended0001193125-13-010805
2012-11-1416:47 ETS-1Registration statement0001533743-12-000006

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.